Coronavirus drug remdesivir gets FDA emergency use authorization

Experimental drug remdesivir has been given authorization by the FDA for COVID-19 treatment in the US, following promising early results in Phase 3 trials last month. The drug, initially developed by Gilead for ebola and other infections, can now be prescribed in hospitals to shorten the recovery time from coronavirus, though the FDA makes no claims about the efficacy of … Continue reading